Botulinum toxin reduces myofascial pain in masseter and temporalis muscles
Study shows botulinum toxin injections reduce myofascial pain for up to two years. Review patient selection criteria for your practice.
A prospective clinical study conducted between 2019 and 2024 evaluated the effectiveness of botulinum toxin injections in treating myofascial pain of the masseter and temporalis muscles. Of 320 enrolled patients, 200 completed the two-year follow-up. Botulinum toxin injections produced large, long-lasting reductions in myofascial pain, with mean pain scores significantly lower at two years compared to baseline.
Pain reduction patterns and timing
The greatest pain reduction occurred during early follow-up periods. At eight weeks, younger patients reported lower pain scores than older patients. Pain reduction continued through the two-year assessment period, though the magnitude of change was greatest in the initial weeks following injection.
Patient factors affecting outcomes
Gender differences in pain reduction were minimal. Married patients experienced more pain reduction than unmarried patients. Increased income and education level correlated with lower pain scores during early follow-up, though these differences diminished by the two-year assessment. These sociodemographic factors suggest that patient characteristics may influence initial treatment response, but long-term outcomes appear more uniform across populations.
Frequently asked questions
How long does botulinum toxin reduce myofascial pain in the jaw muscles?
The study found that botulinum toxin injections produced large, long-lasting pain reduction in the masseter and temporalis muscles, with benefits sustained for at least two years of follow-up.
When do patients experience the greatest pain relief from botulinum toxin injections?
The highest reduction in myofascial pain occurred during early follow-up periods. At eight weeks, younger patients showed lower pain scores compared to older patients.
Do gender or marital status affect botulinum toxin results for myofascial pain?
Gender differences in pain reduction were minimal. Married patients experienced greater pain reduction than unmarried patients, though this difference decreased over the two-year follow-up period.
Does patient income or education level affect botulinum toxin treatment outcomes?
Higher income and education levels correlated with lower pain scores during early follow-up. However, these sociodemographic differences diminished by the two-year assessment.
